Therapeutic management of patent ductus arteriosus
Authors:
- Arpitha ChiruvoluACArpitha Chiruvolu
- Mambarath A. JaleelMJMambarath A. Jaleel
- 1 March 2009
- journal article
- Published by Elsevier in Early Human Development
- Vol. 85 (3) , 151-155
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: Further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP)The Journal of Pediatrics, 2006
- A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosusEuropean Journal of Pediatrics, 2004
- Patent Ductus Arteriosus in the Premature NeonatePediatric Drugs, 1999
- Changing trends in the epidemiology and pathogenesis of neonatal chronic lung diseaseThe Journal of Pediatrics, 1995
- Optimal management of patent ductus arteriosus in the neonate weighing less than 800 gJournal of Pediatric Surgery, 1993
- Indomethacin reduces the risks of severe intraventricular hemorrhageThe Journal of Pediatrics, 1989
- Effects of indomethacin in premature infants with patent ductus arteriosus: Results of a national collaborative studyThe Journal of Pediatrics, 1983
- Prophylactic Indomethacin Therapy for Patent Ductus Arteriosus in Very-Low-Birth-Weight InfantsNew England Journal of Medicine, 1982
- Effect of Fluid Administration on the Development of Symptomatic Patent Ductus Arteriosus and Congestive Heart Failure in Premature InfantsNew England Journal of Medicine, 1980
- Increased risk of bronchopulmonary dysplasia in infants with patent ductus arteriosusThe Journal of Pediatrics, 1979